Ashwin N. Ananthakrishnan, Emily L. McGinley, Kia Saeian – 28 August 2008 – Acute liver failure (ALF) often requires multidisciplinary support. Higher hospital volumes have been associated with better outcomes for surgical procedures, but whether such a relationship exists for ALF has not been explored previously. In this study, our aim was to examine if hospital volume affects mortality from ALF.
Chinsu Liu, Che‐Chuan Loong, Chenn‐Yuan Hsia, Mei‐Yung Tsou, Hsin‐Lin Tsai, Chou‐Fu Wei – 28 August 2008
Ming‐Lung Yu, Chia‐Yen Dai, Jee‐Fu Huang, Wan‐Long Chuang – 28 August 2008
Tamotsu Sagawa, Yasuyuki Yamada, Minoru Takahashi, Yasushi Sato, Masayoshi Kobune, Rishu Takimoto, Junki Fukaura, Satoshi Iyama, Tsutomu Sato, Koji Miyanishi, Takuya Matsunaga, Tetsuji Takayama, Junji Kato, Katsunori Sasaki, Hirofumi Hamada, Yoshiro Niitsu – 28 August 2008 – Although conditionally replicable adenovirus (CRAd) has been used in the clinical treatment of hepatocellular carcinoma (HCC), it suffers from the inherent drawback of having relatively low antitumor activity. Here, we have sought to overcome this drawback.
28 August 2008
Lisa M. Forman – 28 August 2008
Maria Francesca Donato, Francesca Agnelli, Cristina Rigamonti, Eliana Arosio, Massimo Colombo – 28 August 2008
Sebastian Klammt, Steffen R. Mitzner, Jan Stange, Jan Loock, Uwe Heemann, Jörg Emmrich, Emil C. Reisinger, Reinhard Schmidt – 28 August 2008 – Extracorporeal albumin dialysis (ECAD) enables the elimination of albumin bound substances and is used as artificial liver support system. Albumin binding function for the benzodiazepine binding site specific marker Dansylsarcosine was estimated in plasma samples of 22 patients with cirrhosis and hyperbilirubinaemia (ECAD: n = 12; control: n = 10) during a period of 30 days in a randomized controlled clinical ECAD trial.
Yong‐Ning Xin, Shi‐Ying Xuan – 28 August 2008